Learn more about Inocras’s latest news
Inocras Expands WGS-Based Cancer Precision Diagnostics CancerVision to 10 Hospitals
ChiMei Medical Center Adopts Inocras MRDVision and WGS Bioinformatics Platform for Precision Oncology in Taiwan
Inocras Unveils New MRDVision Data, Demonstrating Industry-leading Sensitivity in Head-to-Head Clinical Study Against Leading MRD NGS Assay
Inocras and Center for Data Driven Discovery in Biomedicine Enter Collaborative Research Agreement to Advance Sinonasal Cancer Research
Fore Genomics Partners with Inocras to Launch Pediatric Genetic Health Screening and Newborn Sequencing
Inocras Earns ISO 15189 Accreditation from ANSI ASQ National Accreditation Board (ANAB)
Inocras and Summit Pharmaceuticals International Corporation Announce Collaboration Aim to Transform Clinical Genomics in Japan
Whole Genome MRD Detection with One-in-a-Million LOD: Inocras Launches WGS-Based, Panel-Free MRDVision, Leveraging Ultima ppmSeq Technology
Decoding DNA: Viewpoint with Dennis Quaid teams with Inocras Inc. to discuss personalized genomics
Inocras Unveils Breakthrough Study, Proving Target-Enhanced Whole-Genome Sequencing (TE-WGS) Outperforms Standard Panel Sequencing